STAT
MAY 14, 2025
WASHINGTON — In hours of combative congressional hearings Wednesday, health secretary Robert F. Kennedy Jr. swung between defending sweeping changes at his agency and backtracking on aspects of a reorganization he nevertheless said would be “painful.” He repeatedly cast doubts on reports about negative impacts of the changes, often calling them a “canard.
Pharma Times
MAY 14, 2025
Trial progresses towards topline data expected later in the year
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
MAY 14, 2025
Andrew Witty has resigned as CEO of US health conglomerate UnitedHealth, as the company pulled its financial forecasts for 2025
BioPharma Dive
MAY 14, 2025
The new acquisition from Boston Pharmaceuticals adds to a wave of dealmaking undertaken by GSK to build its liver disease franchise.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
The Pharmacist
MAY 14, 2025
The General Pharmaceutical Council (GPhC) will work more collaboratively with other professional regulators as part of its new five year strategy, chief executive Duncan Rudkin has revealed. The strategy, which is due to be launched 'soon', will set out key themes including collaboration and integration. This is intended to recognise that this is how care […] The post Other regulators could enforce GPhC standards, suggests chief exec appeared first on The Pharmacist.
Pharmafile
MAY 14, 2025
Global biopharma company, Secarna Pharmaceuticals, and biotech investor, Cure.Bio, have announced signing a research and option agreement, intending to accelerate the development of Secarna’s oligonucleotide therapeutics. Under the agreement, Secarna will leverage its OligoCreator platform in exchange for a technology access fee, research funding and warrants to purchase shares in Cure.Bio upon the achievement of […] The post Secarna Pharmaceuticals and Curie.Bio portfolio company en
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
PharmExec
MAY 14, 2025
Results from the Phase III REAL8 basket study found that once-weekly Sogroya was effective in children with growth disorders, including those born small for gestational age, with Noonan syndrome, or idiopathic short stature.
Pharma Times
MAY 14, 2025
FDA recognises KER-0193 as a potential therapy for rare paediatric disease
Pharmaceutical Technology
MAY 14, 2025
The deal comes at a time of revival into liver disease treatment investment as market opportunity beckons.
Pharmacy Times
MAY 14, 2025
The FDA approves belzutifan, the first oral treatment for pheochromocytoma and paraganglioma, offering a new treatment pathway for patients with these rare tumors.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology
MAY 14, 2025
Recipharm has joined forces with ProductLife Group (PLG) to support (bio)pharmaceutical firms in expediting market approval and trial time.
PharmExec
MAY 14, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmacy Times
MAY 14, 2025
Emrelis is a groundbreaking treatment for advanced non-small cell lung cancer, targeting high c-Met protein overexpression.
Drug Patent Watch
MAY 14, 2025
"Reviving Old Medicines: How AI-Powered Repurposing is Revolutionizing the Pharmaceutical Industry The pharmaceutical industry is on the cusp of a revolution, driven by the power of computational drug repurposing. By leveraging cutting-edge AI and machine learning algorithms, researchers are breathing new life into old medicines, unlocking unprecedented potential for treating a wide range of diseases.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
PharmExec
MAY 14, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
The Pharmacist
MAY 14, 2025
The incoming Royal College of Pharmacy needs to offer something that 'excites' and 'interests' pharmacists who are not currently members of the Royal Pharmaceutical Society (RPS), chief pharmaceutical officer (CPhO) for England David Webb has suggested. The recent vote was an 'important first step' with the membership who participated giving 'a clear signal around moving […] The post Royal College of Pharmacy needs to excite and interest current non-members appeared first on The Pharmacist
Drug Patent Watch
MAY 14, 2025
"The Prescription for Change: How PBM's are Ripping the Rhythm of the Pharmaceutical Industry Imagine a music industry where a single middleman controlled access to every song, dictating who could play them, when, and at what price. That's essentially the world of Pharmacy Benefit Managers (PBMs) in the pharmaceutical industry. In this exclusive article, we delve into the complex web of PBM's and their impact on the pharmacy landscape.
World Pharma News
MAY 14, 2025
The Food and Drug Administration's approval in 2023 of lecanemab - a novel Alzheimer's therapy shown in clinical trials to modestly slow disease progression - was met with enthusiasm by many in the field as it represented the first medication of its kind able to influence the disease. But side effects - brain swelling and bleeding - emerged during clinical trials that have left some patients and physicians hesitant about the treatment.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
pharmaphorum
MAY 14, 2025
GSK decided to abandon a TIGIT-targeted drug for cancer this week, then hatched a plan to replace it with a candidate for liver disease MASH.
BioPharma Dive
MAY 14, 2025
The research collaboration, under which Septerna will receive more than $200 million in upfront and near-term fees, is the latest deal Novo has struck to expand its obesity pipeline.
Pharmaceutical Technology
MAY 14, 2025
Novo Nordisk is doubling down on its oral drug strategy for obesity with a new partnership worth up to $2.2bn with Septerna.
pharmaphorum
MAY 14, 2025
Andrew Witty has resigned as CEO of US health conglomerate UnitedHealth, as the company pulled its financial forecasts for 2025.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
PharmExec
MAY 14, 2025
Under the agreement, GSK will acquire BP Asset IX, a subsidiary of Boston Pharmaceuticals, for up to $2 billion in total cash consideration, including $1.2 billion upfront and up to $800 million in milestone payments.
BioPharma Dive
MAY 14, 2025
Shareholders in Bluebird now have a choice of two offers from would-be acquirers Carlyle and SK Capital. Elsewhere, Cytokinetics shared more aficamten data and BridgeBio started a new kind of Attruby trial.
Welltopia Pharmacy
MAY 14, 2025
American Ginseng Benefits include natural support for stress, focus, and blood sugar balancelearn how it works, why it’s unique, and how to choose the best supplement for you. What Makes American Ginseng Unique American ginseng benefits (Panax quinquefolius) stand out from other herbs in the wellness world.
Pharmacy Times
MAY 14, 2025
Like other high-risk groups, children with sickle cell disease have a heightened risk of invasive pneumococcal disease, even if they receive proper pneumococcal conjugate vaccine coverage.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
FDA Law Blog: Biosimilars
MAY 14, 2025
By Mark A. Tobolowsky & Mark I. Schwartz In early April, Cellares became the first company to announce receipt of an Advanced Manufacturing Technology (AMT) designation from FDA. The designation was granted by CBER to Cellares for its automated cell therapy platform, the Cell Shuttle. We were excited to see the news and look forward to seeing the full implementation of the AMT program and its potential benefits.
Pharmacy Times
MAY 14, 2025
New trial results reveal icotrokinra's effectiveness in achieving significant skin clearance for challenging scalp and genital psoriasis.
Pharma Marketing Network
MAY 14, 2025
In todays digital-first healthcare landscape, programmatic display ads have become a cornerstone of pharmaceutical marketing strategies. By leveraging automated, data-driven ad placements, pharma brands can reach healthcare professionals (HCPs) and patients with unprecedented precision and efficiency. This guide delves into the essentials of programmatic advertising, its benefits, and best practices for pharma marketers.
Pharmacy Times
MAY 14, 2025
The seasonal surge in skin irritations underscores the ongoing need for effective and convenient remedies.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Expert insights. Personalized for you.
300 
Let's personalize your content